PolyPeptide Group

Highly Engaged Employees

PolyPeptide Group, established in 1952 and officially founded in 1996, is a Contract Development & Manufacturing Organization (CDMO) specializing in proprietary and generic GMP-grade peptides. Operating within the Pharmaceutical and Healthcare industries, the company leverages its core expertise in peptide synthesis to serve clients in biotechnology and pharmaceutical sectors. With a history spanning decades, PolyPeptide Group has positioned itself as a key player in the development and large-scale production of complex peptide molecules.

The company operates with an employee range of 1,000 - 5,000 individuals and maintains a global presence with 9 locations. PolyPeptide Group's product portfolio encompasses custom peptide development, contract manufacturing, and the production of GMP-grade peptides for various phases of drug development, from research to commercial scale. Their capabilities extend to both solid and liquid phase synthesis, including radioactive isotopes for specialized applications. To understand the human capital driving these operations, one can Meet PolyPeptide Group's team for insights into their leadership and organizational structure.

PolyPeptide Group reported a revenue of $369.9M. The company's strategic focus on peptide manufacturing positions it within a specialized segment of the pharmaceutical supply chain. Its extensive list of hashtags indicates a broad operational scope, touching upon various aspects of employee benefits, operational scale, and market reach across regions like North America, Europe, and Asia. The company's commitment to quality and scale is evident in its service offerings, catering to both small-scale custom research needs and large-scale commercial production processes.